Want to see TSE:VXL full AI Analyst Report?
Vaxil Bio (VXL) Financial Statements
Vaxil Bio Financial Overview
Vaxil Bio's market cap is currently $398.40K. The company's EPS TTM is $0.10; its P/E ratio is 1.00; Vaxil Bio has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ -2.00K | $ -25.00K |
| Operating Income | $ -179.00K | $ -196.00K | $ -254.00K | $ -584.00K | $ -986.00K |
| EBITDA | $ -179.00K | $ -30.00K | $ -252.00K | $ -582.00K | $ -961.00K |
| Net Income | $ 522.00K | $ -178.00K | $ -254.00 | $ -584.00K | $ -986.00K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 671.00K | $ 714.00K | $ 938.00K | $ 1.51M | $ 2.24M |
| Total Assets | $ 1.37M | $ 733.00K | $ 976.00K | $ 1.54M | $ 2.29M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -671.00K | $ -448.00K | $ -938.00K | $ -1.51M | $ -2.24M |
| Total Liabilities | $ 5.00K | $ 17.00K | $ 85.00K | $ 405.00K | $ 585.00K |
| Stockholders' Equity | $ 1.36M | $ 716.00K | $ 891.00K | $ 1.14M | $ 1.70M |
| Cash Flow | |||||
| Free Cash Flow | $ -170.00K | $ -240.00K | $ -561.00K | $ -734.00K | $ -1.08M |
| Operating Cash Flow | $ -170.00K | $ -240.00K | $ -561.00K | $ -734.00K | $ -1.08M |
| Investing Cash Flow | $ 266.00K | $ -250.00K | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 127.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ 1.81M |
Currency in CAD